Literature DB >> 2901609

Circadian variation of total ischaemic burden and its alteration with anti-anginal agents.

D Mulcahy1, J Keegan, D Cunningham, A Quyyumi, P Crean, A Park, C Wright, K Fox.   

Abstract

6264 hours of ambulatory ST segment monitoring of 150 unselected patients with proven coronary artery disease, who were off all routine anti-anginal treatments, showed 598 ischaemic episodes, of which 446 (75%) were silent (symptom-free). Most (68%) ischaemic episodes occurred between 0730 and 1930, with a peak in the morning and a lesser peak in the evening. Two subgroups were studied further in double-blind controlled trials: 33 patients had a total of 1313 hours of ST segment monitoring while treated with nifedipine; and 41 patients a total of 1581 hours while treated with atenolol. Nifedipine did not alter the circadian pattern of ischaemic episodes; atenolol abolished the morning peak, and the peak incidence of ischaemia then occurred in the evening. Circadian patterns for total duration of ischaemic episodes corresponded closely to those of episodes of ischaemia, and were similarly altered by treatment. The circadian pattern of silent ischaemic episodes and their total duration were very similar to those of total ischaemia for the group as a whole and the different subgroups. This circadian distribution of ischaemic episodes and the observed changes with treatment resemble the reported circadian variation of acute myocardial infarction and sudden death.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901609     DOI: 10.1016/s0140-6736(88)92414-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

Review 1.  Chronotherapeutics: are there meaningful differences among antihypertensive drugs?

Authors:  L Poirier; J Lefebvre; Y Lacourciere
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

2.  Clinical pharmacology-physiology conference. A chrono-therapeutic approach to the treatment of hypertension.

Authors:  D T Lowenthal; J Estrada; R Cott
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 3.  Avoiding nitrate tolerance.

Authors:  J C Cowan
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

4.  The circadian heart rate but not blood pressure profile is influenced by the timing of beta-blocker administration in hypertensives.

Authors:  S Sundberg; O J Luurila; A Kohvakka; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Should we get up in the morning? Observations on circadian variations in cardiac events.

Authors:  D Mulcahy; H Purcell; K Fox
Journal:  Br Heart J       Date:  1991-06

Review 6.  Silent myocardial ischaemia. Implications for therapy.

Authors:  N G Uren; D P Lipkin
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 7.  Rationale for treatment of silent myocardial ischemia: focus on nifedipine.

Authors:  R W Nesto
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 8.  Circadian rhythm and cardiovascular disease.

Authors:  Elizabeth Shaw; Geoffrey H Tofler
Journal:  Curr Atheroscler Rep       Date:  2009-07       Impact factor: 5.113

Review 9.  Nitrates in silent ischemia.

Authors:  H Purcell; D Mulcahy; K Fox
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

10.  Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.

Authors:  H Ikram; C J Low; T M Shirlaw; S G Foy; I G Crozier; A M Richards; N S Khurmi; R J Horsburgh
Journal:  Br Heart J       Date:  1994-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.